A cure for Covid? Israeli team claims new drug has 96% success rate

The latest Jewish News

Read this week’s digital edition

Click Here

A cure for Covid? Israeli team claims new drug has 96% success rate

Researchers at Tel Aviv’s biggest hospital report what could be a game-changer in the fight against the pandemic.

Jenni Frazer is a freelance journalist

Workers wearing protective suits disinfect a bus as a preventive measure amid fears over the spread of the coronavirus
Workers wearing protective suits disinfect a bus as a preventive measure amid fears over the spread of the coronavirus

Researchers at Tel Aviv’s biggest hospital, Ichilov, are reporting what could be a major game-changer in the fight against the Covid-19 virus — a drug which is curing corona patients with a 96 per cent success rate.

Thirty patients who were suffering from moderate or serious levels of Corona were given the new EXO-CD24 drug, developed by Professor Nadir Arber from Ichilov’s Cancer Prevention Centre. Only one patient failed to respond: 29 others showed “a marked improvement” within two days of taking the new drug.

Professor Arber says the treatment is “effective and inexpensive.

The medicine is administered through inhalation, once a day, in a procedure that takes only a few minutes, for five days,”, he said.

The 29 who improved after taking the drug were able to leave hospital between three and five days later.

Now, Professor Ronni Gamzu, the former state coronavirus “czar”, who has returned to his role as chief executive of Ichilov, says he will personally assist Professor Arber in getting the green light from Israel’s Health Ministry in order to test the medication on a wider pool of patients. 

He said: “‘I’m proud that here at Ichilov we are among the world leaders in finding the cure for the horrible epidemic”.

A similar treatment has been announced by Hadassah Medical Centre in Jerusalem. In their trial, 21 patients in critical condition — who had underlying health conditions — received a drug called Allocetra. According to the doctors, 19 patients recovered within six days and were released from the hospital on average after eight days.

The drug was developed by Professor Dror Mevorach. director of Hadassah’s Research Centre for Rheumatology and Internal Medicine.

Support your Jewish community. Support your Jewish News

Thank you for helping to make Jewish News the leading source of news and opinion for the UK Jewish community. Today we're asking for your invaluable help to continue putting our community first in everything we do.

Unlike other Jewish media, we do not charge for content. That won’t change. Because we are free, we rely on advertising to cover our costs. This vital lifeline, which has dropped in recent years, has fallen further due to coronavirus.

For as little as £5 a month you can help sustain the vital work we do in celebrating and standing up for Jewish life in Britain.

Jewish News holds our community together and keeps us connected. Like a synagogue, it’s where people turn to feel part of something bigger. It also proudly shows the rest of Britain the vibrancy and rich culture of modern Jewish life.

You can make a quick and easy one-off or monthly contribution of £5, £10, £20 or any other sum you’re comfortable with.

100% of your donation will help us continue celebrating our community, in all its dynamic diversity...


Being a community platform means so much more than producing a newspaper and website. One of our proudest roles is media partnering with our invaluable charities to amplify the outstanding work they do to help us all.


There’s no shortage of oys in the world but Jewish News takes every opportunity to celebrate the joys too, through projects like Night of Heroes, 40 Under 40 and other compelling countdowns that make the community kvell with pride.


In the first collaboration between media outlets from different faiths, Jewish News worked with British Muslim TV and Church Times to produce a list of young activists leading the way on interfaith understanding.


Royal Mail issued a stamp honouring Holocaust hero Sir Nicholas Winton after a Jewish News campaign attracted more than 100,000 backers. Jewish News also produces special editions of the paper highlighting pressing issues including mental health and Holocaust remembrance.

Easy access

In an age when news is readily accessible, Jewish News provides high-quality content free online and offline, removing any financial barriers to connecting people.

Voice of our community to wider society

The Jewish News team regularly appears on TV, radio and on the pages of the national press to comment on stories about the Jewish community. Easy access to the paper on the streets of London also means Jewish News provides an invaluable window into the community for the country at large.

We hope you agree all this is worth preserving.

read more: